Status:
COMPLETED
Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Alzheimer Disease
Eligibility:
All Genders
50-100 years
Phase:
NA
Brief Summary
Therapeutic education expands in Alzheimer's Disease management in France. Several studies revealed a positive impact on caregiver's burden and/or quality of life. The purpose of this study, is to det...
Detailed Description
This study is designed to determine whether a therapeutic educational programme for both AD patients, in community dwelling, and their primary caregivers improves patient's quality of life, after two ...
Eligibility Criteria
Inclusion
- patient suffering from mild to moderately severe Alzheimer's disease patients (MMSE 11 to 26)
- in community dwelling
- with an informal caregiver (person living with the patient or providing care 3 times a week or 8 hours per week)
- is informed and has given his/her consent
- whom caregiver is informed and has given his/her consent
Exclusion
- patient with other type of dementia
- living in nursing home or long term care
- with no caregiver
- not informed or has not given his/her consent
- whom caregiver is not informed or has not given his/her consent
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT01796314
Start Date
January 1 2013
End Date
February 1 2017
Last Update
November 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Toulouse, Hôtel-Dieu, 2 rue Viguerie
Toulouse, France, 31052